c‐myc oncogene expression in colorectal cancer

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Cancer

• Publication date

  1987-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1097-0142(19870401)59:7<1289::AID-CNCR2820590710>3.0.CO;2-OPMID 3545431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The tumour promoter 12-O-tetradecanoylphorbol-13-acetate increases the activities of some peroxisome-associated enzymes in in vitro cell culture.

  1986cited by this paper
• The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer.

  1986cited by this paper
• Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

  1985cited by this paper
• Detection of the c-myc oncogene product in testicular cancer.

  1985cited by this paper
• Growth factors and oncogenes.

  1985cited by this paper
• Expression of p21ras in fresh primary and metastatic human colorectal tumors.

  1985cited by this paper
• A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material.

  1985cited by this paper
• Metabolism of c‐myc gene products: c‐myc mRNA and protein expression in the cell cycle.

  1985cited by this paper
• Truncation of exon 1 from the c‐myc gene results in prolonged c‐myc mRNa stability.

  1985cited by this paper
• Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours.

  1985cited by this paper
• Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins.

  1985cited by this paper
• Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum.

  1984cited by this paper
• Expression of cellular oncogenes in human malignancies.

  1984cited by this paper
• Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation.

  1984cited by this paper
• Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

  1983cited by this paper
• Expression of a cellular oncogene during liver regeneration.

  1983cited by this paper
• Translocation joins c-myc and immunoglobulin γ1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene

  1983cited by this paper
• Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29

  1983cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC.

  2026cites this paper
• Peptides as multifunctional players in cancer therapy

  2023cites this paper
• TRIM55 inhibits colorectal cancer development via enhancing protein degradation of c‐Myc

  2023cites this paper
• MicroRNA-378a-3p prevents initiation and growth of colorectal cancer by fine tuning polyamine synthesis

  2022cites this paper
• Validation of Urinary Charged Metabolite Profiles in Colorectal Cancer Using Capillary Electrophoresis-Mass Spectrometry

  2022cites this paper
• Ligustilide from Radix Angelica Sinensis prevents the migration of vascular smooth muscle A7r5 cells based on network pharmacology and experimental verification

  2022cites this paper
• A Pilot Study Investigating the Expression Levels of Pluripotency-Associated Genes in Rectal Swab Samples for Colorectal Polyp and Cancer Diagnosis and Prognosis

  2021cites this paper
• Molecular Subclassification Based on Crosstalk Analysis Improves Prediction of Prognosis in Colorectal Cancer

  2021influential citation
• Synergistic antitumor activity of DHA and JQ1 in colorectal carcinoma.

  2020cites this paper
• Targeting LncRNA EPIC1 to inhibit human colon cancer cell progression

  2020cites this paper
• Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer

  2020cites this paper
• Stomach-specific c-Myc overexpression drives gastric adenoma in mice through AKT/mammalian target of rapamycin signaling

  2020cites this paper
• Nuclear‐mitochondrial crosstalk: On the role of the nuclear receptor liver receptor homolog‐1 (NR5A2) in the regulation of mitochondrial metabolism, cell survival, and cancer

  2020cites this paper
• Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress

  2019cites this paper
• Integrin α6β4 in Colorectal Cancer: Expression, Regulation, Functional Alterations and Use as a Biomarker

  2019cites this paper
• Inflammation‐dependent overexpression of c‐Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis‐associated cancer

  2019cites this paper
• miR‐144 suppresses cell proliferation and migration in colorectal cancer by targeting NRAS

  2019cites this paper
• Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer

  2019cites this paper
• Dormancy in cancer

  2019cites this paper
• PAF-Myc-Controlled Cell Stemness Is Required for Intestinal Regeneration and Tumorigenesis.

  2018cites this paper
• MYC Regulates α6 Integrin Subunit Expression and Splicing Under Its Pro-Proliferative ITGA6A Form in Colorectal Cancer Cells

  2018cites this paper
• Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions

  2018cites this paper
• 1 Identification of Prognostic Biomarker Signatures 2 and Candidate Drugs in Colorectal Cancer : Insights 3 from Systems Biology Analysis 4

  2018cites this paper
• Identification of prognostic biomarker signatures and 2 candidate drugs in colorectal cancer : Insights from 3 systems biology analysis 4

  2018cites this paper
• Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis

  2018cites this paper
• MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling

  2018cites this paper
• Increased Musashi-2 and Decreased NUMB Protein Levels Observed in Human Colorectal Cancer are reverted to Normal Levels by ATRA-Induced Cell Differentiation

  2018cites this paper
• Knockdown of long non-coding RNA prostate cancer-associated ncRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells

  2017cites this paper
• Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer

  2017cites this paper
• FoxM1: Repurposing an oncogene as a biomarker.

  2017cites this paper
• MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signaling.

  2017cites this paper
• A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer

  2017cites this paper
• Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis

  2016cites this paper
• The role of Pygo2 during intestinal tumor initiation and progression in vivo

  2016cites this paper
• The MYC 3′ Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells

  2016cites this paper
• Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer

  2015cites this paper
• Linc-RoR promotes c-Myc expression through hnRNP I and AUF1

  2015cites this paper
• Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells

  2015cites this paper
• Genetic unraveling of colorectal cancer

  2014cites this paper
• Expressions of oncogenes c-fos and c-myc in skin lesion of cutaneous squamous cell carcinoma.

  2014cites this paper
• Enhancement of c-Myc degradation by Bloom ( BLM ) helicase leads to delayed tumor initiation

  2013cites this paper
• Testing the functional equivalence of the mammalian Dlx5 and Dlx6 proteins

  2013cites this paper
• Enhancement of c-Myc degradation by BLM helicase leads to delayed tumor initiation

  2013cites this paper
• REGγ is associated with multiple oncogenic pathways in human cancers

  2012cites this paper
• Relative quantification of the proteomic changes associated with the mycotoxin zearalenone in the H295R steroidogenesis model.

  2011cites this paper
• LIN28B fosters colon cancer migration, invasion, and transformation through let-7 dependent and independent mechanisms

  2011cites this paper
• The role of oncogenes in gastrointestinal cancer.

  2010cites this paper
• Lin28B, let-7, and the molecular pathogenesis of colon cancer

  2010cites this paper
• Expression of cm yc , bcl-2 and p 53 Proteins in A denocarcinom as of Lung

  2010cites this paper
• Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.

  2009cites this paper
• DLX5 (Distal-less Homeobox 5) Promotes Tumor Cell Proliferation by Transcriptionally Regulating MYC*

  2009cites this paper
• Recent initiatives in head and neck cancer research: an overview.

  2008cites this paper
• Nuclear receptors, intestinal architecture and colon cancer: an intriguing link

  2008cites this paper
• mRNA stability and cancer: an emerging link?

  2007cites this paper
• CHAPTER 3 – Genetics and Epigenetics in Cancer Biology

  2006cites this paper
• Biology of colorectal liver metastases: A review

  2006cites this paper
• c-Myc, genome instability, and tumorigenesis: the devil is in the details.

  2006cites this paper
• Targeting the active β-catenin pathway to treat cancer cells

  2006cites this paper
• Targeting the active beta-catenin pathway to treat cancer cells.

  2006cites this paper
• Advances in Brief Genomic Instability in Colorectal Cancer : Relationship to Clinicopathological Variables and Family History 1

  2006cites this paper
• p53, Bcl-2 and C-Myc Expressions in Colorectal Carcinoma Associated with Schistosomiasis in Egypt

  2005cites this paper
• HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation

  2005cites this paper
• Study of Cancer-Prone Patients

  2005cites this paper
• c-myc Overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas

  2005cites this paper
• Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer

  2005cites this paper
• c-myc Oncogene product P62C-rYc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy

  2005cites this paper
• Identification of MYCBP as a β-catenin/LEF-1 target using DNA microarray analysis

  2005cites this paper
• Current status of tumor markers in large bowel cancer

  2005cites this paper
• Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.

  2005cites this paper
• Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation.

  2005cites this paper
• Increased expression of a Myc target gene Mina53 in human colon cancer.

  2004cites this paper
• Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element.

  2004cites this paper
• BETA-CATENIN IN HNPCC COLON TUMOURS

  2004cites this paper
• Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene.

  2004cites this paper
• K-RAS point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma.

  2004cites this paper
• Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups.

  2004cites this paper
• An immunohistochemical study of beta-catenin in HNPCC colon tumours

  2004cites this paper
• D epartm ent of Pathology, St V incent's H ospital, C atholic U niversity, Suwon, K orea

  2004cites this paper
• c-myc oncoprotein levels in bladder cancer

  2004cites this paper
• The expression of c-myc, bcl-2 and p53 proteins in adenocarcinomas of lung.

  2004cites this paper
• c-myc in bladder cancer Clinical findings and analysis of mechanism

  2004cites this paper
• Tcf binding sequence and position determines β‐catenin and Lef‐1 responsiveness of MMP‐7 promoters

  2004cites this paper
• Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation.

  2004cites this paper
• Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses

  2004influential citation
• Apoptosis and Cancer

  2003cites this paper
• Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma.

  2003cites this paper
• The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway.

  2002cites this paper
• Clinical Correlation of c-erbB-2, p53, bcl-2, and c-myc Expression in Patients with Breast Cancer.

  2002cites this paper
• Elevated protein expression of cyclin D1 and Fra‐1 but decreased expression of c‐Myc in human colorectal adenocarcinomas overexpressing β‐catenin

  2002cites this paper
• Molecular causes of colon cancer

  2002cites this paper
• Wnt/Beta-Catenin/Tcf Signaling: A Critical Pathway in Gastrointestinal Tumorigenesis

  2002cites this paper
• Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.

  2001cites this paper
• Overexpression of an mRNA-binding protein in human colorectal cancer

  2001cites this paper
• Evaluation of myc and chromosome 8 copy number in colorectal cancer using interphase cytogenetics.

  2001cites this paper
• Elevated levels of RanBP7 mRNA in colorectal carcinoma are associated with increased proliferation and are similar to the transcription pattern of the proto-oncogene c-myc.

  2000cites this paper
• Endocrine-Related Cancer ( 2000 ) 7 143 – 164 c-Myc in breast cancer

  2000cites this paper
• [Colorectal cancer: inducing circumstances (etiology) and pathogenic paths (pathogenesis].

  2000cites this paper
• Cáncer colorrectal: circunstancias inductoras (etiología) y caminos de realización (patogenia)

  2000cites this paper
• Report on the state of young people's health in the European Union

  2000cites this paper
• c-Myc in breast cancer.

  2000cites this paper